This drug has been approved at a time when India is in the grip of COVID-19 epidemic, second wave and it has had a profound impact on the health structure of the country.
Union Health Minister Dr. Harsh Vardhan at the launch of 2DG medicine
2-Doxy-D-glucose (2DG), a new drug developed by DRDO for corona infected patients has been launched in India. Defense Minister Rajnath Singh and Health Minister Dr. Harsh Vardhan released the first batch of medicine. Union Health Minister Dr Harsh Vardhan said on Monday that the anti-covid drug 2-deoxy-D-glucose (2-DG), developed by the Defense Research and Development Organization (DRDO), has been shown to cause COVID-19 infection (Coronavirus) and The time it takes to recover from oxygen dependence will be reduced.
During the launch of the first batch of 2-DG medicine, Harsh Vardhan said, “This (anti-covid drug 2DG) is our first indigenous research to fight the corona epidemic under the support of DRDO and led by Union Defense Minister Rajnath Singh.” He said, I hope that this medicine will be used prominently not only in India but all over the world ‘.
‘2-DG’ Corona’s first indigenous drug
Dr. Harsh Vardhan said, ‘Today is the most enjoyable day for all of us in the month of May. We have been fighting COVID’s war for more than a year. It is our first indigenous drug under the defense sector outgo, it has full potential to reduce the outbreak of COVID virus from a scientific point of view ‘.
He said, ‘We have been fighting the corona since last year and our scientists have also prepared the vaccine. This vaccine has also become available to the people. I thank the DRDO and its scientists and congratulate them. We have seen that DRDO under the leadership of Prime Minister Narendra Modi has played an important role in the war against COVID-19 ‘.
This drug reduces oxygen dependence
Emergency use of the 2-deoxy-D-glucose (2-DG) drug on patients with moderate and severe symptoms of COVID-19 has been approved by the Drug Controller General of India (DGCI). On May 8, the Defense Ministry said in a statement that clinical trials of 2-deoxy-D-glucose (2-DG) showed that it helps reduce oxygen dependence of hospitalized patients. Also, patients recover faster with this medicine.
This drug has been approved at a time when India is in the grip of COVID-19 epidemic, second wave and it has had a profound impact on the health structure of the country. This drug of COVID-19 has been made by DRDO’s leading laboratory Institute of Nuclear Medicine and Allied Sciences (INMAS) in association with Dr. Reddy’s Laboratory of Hyderabad. This medicine will be available in the form of powder in a sachet, which the patients have to drink after mixing it with water.
read this also: PM Modi poster case: petition filed against arrest in Supreme Court, demand for cancellation of FIR